Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma.
about
What is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?Intensity-modulated radiotherapy outcomes for oropharyngeal squamous cell carcinoma patients stratified by p16 status.Is There a Role for Robotic Surgery in the Treatment of Head and Neck Cancer?Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22).Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial.Prospective imaging assessment of mortality risk after head-and-neck radiotherapy.DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy.Outcomes of serial dilation for high-grade radiation-related esophageal strictures in head and neck cancer patients.PET/CT staging followed by Intensity-Modulated Radiotherapy (IMRT) improves treatment outcome of locally advanced pharyngeal carcinoma: a matched-pair comparisonClinical evaluation of intensity-modulated radiotherapy for head and neck cancers.Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiationProton radiation therapy for head and neck cancer.Clinical application of intensity-modulated radiotherapy for head and neck cancer.Oncologic Outcomes After Transoral Robotic Surgery: A Multi-institutional StudyThe treatment outcome and radiation-induced toxicity for patients with head and neck carcinoma in the IMRT era: a systematic review with dosimetric and clinical parameters.Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer.Current trends in initial management of oropharyngeal cancer: the declining use of open surgery.Proton beam radiation therapy for head and neck malignancies.Clinical heterogeneity and tumor control probability.Intensity-modulated radiotherapy for oropharyngeal squamous cell carcinoma.Robotic surgery for oropharynx cancer: promise, challenges, and future directions.IMRT and IGRT in head and neck cancer: Have we delivered what we promised?A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: a systematic review.Impact of race on oropharyngeal squamous cell carcinoma presentation and outcomes among veterans.AHNS Series: Do you know your guidelines?Principles of radiation therapy for head and neck cancer: A review of the National Comprehensive Cancer Network guidelines.Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation.A phase I/II study of altered fractionated IMRT alone for intermediate T-stage oropharyngeal carcinoma.Ipsilateral radiotherapy for squamous cell carcinoma of the tonsil.Intensity-modulated radiotherapy increases dose to the brachial plexus compared with conventional radiotherapy for head and neck cancer.Intensity-modulated radiation therapy as primary treatment for oropharyngeal squamous cell carcinoma.Improved survival using intensity-modulated radiation therapy in head and neck cancers: a SEER-Medicare analysis.Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.Staging Neck Dissection and Transoral Robotic Surgery Treatment Algorithm in Palatine Tonsil Cancer.Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience.Initial clinical experience with helical tomotherapy for head and neck cancer.Concurrent chemotherapy with intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the larynx and oropharynx: a retrospective single-institution analysis.Clinical outcomes after local field conformal reirradiation of patients with retropharyngeal nodal metastasis.Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer.
P2860
Q27026269-7DD7F4B6-1CC8-4A1F-803D-4283E37E9731Q30450366-DE1B0783-B817-4929-B4D0-16920CA3B659Q33652561-F94287FA-8B94-4FDA-BFEB-894A72585BA1Q33756093-A0EE2F46-E86B-4A34-84B6-F8B539337A16Q34743124-1DF54F4E-7023-43BF-8F55-A5F3AF1E2484Q34768949-016C9F74-8CE7-435A-88F6-802379E4D132Q34974246-65746934-D873-4094-9151-89FB396EE264Q35224516-6C6A16EC-D4A8-456F-A009-5354E088CEB1Q35901104-E5A7DA55-89BB-4F7D-82E2-3948D20031ACQ36343896-95E94052-1657-4919-BBAB-DD20AE63D5DAQ36655507-6D204032-CD5E-4C5F-BCCD-B71A2780AA77Q37169225-B1DAB5EA-46E2-4C6F-9C08-571E0D64CAAAQ37217016-1801667D-0EDD-48DC-9DBC-EB62D70788F4Q37248881-71C5F56E-8F8F-40E6-AC90-4B1AA30442F2Q37283393-AC112530-5753-451F-9532-0BF9A270B3D1Q37337056-2A6A9700-21C7-4423-ADDE-00BB60933D47Q37623578-7E4EC3A6-FFEC-43C6-9EC0-B7AA5C7F2989Q37738175-0B91CFD3-E768-461E-A315-880CDF0919D7Q37760509-844E9292-0FC0-4871-9445-6CF36632289DQ37799582-BFA46769-A39B-4268-8B1B-0B6F15C36A0BQ37981985-70CEADA4-06E9-4343-A6CC-7D78986ECECFQ38038841-2B83E15E-1079-42B4-A0D9-127DDD7B873CQ38204303-CA2A22B0-1D4A-4315-B1D5-EFD31CE17FF6Q38225964-77BF30DB-B65C-4CBD-A05A-C93973D97A35Q38788906-42D604A3-7903-4DEA-A8B6-CAC1A04C6866Q39448913-22850CC8-BC22-4D31-997C-E48AA9E2F64EQ39843033-C36EB29B-9060-4158-8F6A-04BE0784C99FQ40681266-2C38807D-DDB6-495E-B272-57705740437BQ42419380-7CEED7F3-D84A-4C94-A7ED-BA60C383C08DQ44506873-ABA883A8-B6AC-4484-8FDB-11A8012236B3Q44873720-A26FE8D6-3021-4E38-9173-0A2E9A91AFEFQ45919154-676B6EAB-EEFD-4ED2-A2C3-770839D4E494Q46053548-58D6E920-F022-4E22-BB57-9935BCF151A6Q46070865-D84E1FAB-5858-48A1-ADA6-528F7A74657BQ46330354-192C5116-C2B4-42AD-A16E-13292BC2849EQ46771718-A7E13AC8-4811-4724-83B6-A055E2B53125Q46823759-7B19EC98-E3AD-4109-9E55-7E0F8C62ABC1Q50619867-4C88E4C7-4CA1-431A-988D-614C841C456E
P2860
Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Disease-control rates followin ...... imary oropharyngeal carcinoma.
@ast
Disease-control rates followin ...... imary oropharyngeal carcinoma.
@en
Disease-control rates followin ...... imary oropharyngeal carcinoma.
@nl
type
label
Disease-control rates followin ...... imary oropharyngeal carcinoma.
@ast
Disease-control rates followin ...... imary oropharyngeal carcinoma.
@en
Disease-control rates followin ...... imary oropharyngeal carcinoma.
@nl
prefLabel
Disease-control rates followin ...... imary oropharyngeal carcinoma.
@ast
Disease-control rates followin ...... imary oropharyngeal carcinoma.
@en
Disease-control rates followin ...... imary oropharyngeal carcinoma.
@nl
P2093
P2860
P1476
Disease-control rates followin ...... imary oropharyngeal carcinoma.
@en
P2093
Adam S Garden
Brian Mason
George H Perkins
K Kian Ang
Pei-Fong Wong
Sam S Tung
William H Morrison
P2860
P304
P356
10.1016/J.IJROBP.2006.08.078
P407
P577
2006-12-04T00:00:00Z